Full Name
XXX Folefac Aminkeng
(not current staff)
Main Affiliation


Results 1-20 of 47 (Search time: 0.012 seconds).

Issue DateTitleAuthor(s)
11-Sep-2015A coding variant in RARG confers susceptibility to anthracycline-induced cardiotoxicity in childhood cancerAminkeng, Folefac ; Bhavsar, Amit P; Visscher, Henk; Rassekh, Shahrad R; Li, Yuling; Lee, Jong W; Brunham, Liam R; Caron, Huib N; van Dalen, Elvira C; Kremer, Leontien C; van der Pal, Helena J; Amstutz, Ursula; Rieder, Michael J; Bernstein, Daniel; Carleton, Bruce C; Hayden, Michael R ; Ross, Colin JD
21-Mar-2018An initial health economic evaluation of pharmacogenomic testing in patients treated for childhood cancer with anthracyclinesDionne, Francois; Aminkeng, Folefac ; Bhavsar, Amit P; Groeneweg, Gabriella; Smith, Anne ; Visscher, Henk; Rassekh, Shahrad Rod; Ross, Colin; Carleton, Bruce
3Aug-2023An Introductory Tutorial on Cardiovascular Pharmacogenetics for Healthcare ProvidersOni-Orisan, Akinyemi; Tuteja, Sony; Hoffecker, Glenda; Smith, D Max; Castrichini, Matteo; Crews, Kristine R; Murphy, William A; Nguyen, Nam HK; Huang, Yimei; Lteif, Christelle; Friede, Kevin A; Tantisira, Kelan; XXX Folefac Aminkeng ; Voora, Deepak; Cavallari, Larisa H; Whirl-Carrillo, Michelle; Duarte, Julio D; Luzum, Jasmine A
416-Oct-2017Association and clinical utility of NAT2 in the prediction of isoniazid-induced liver injury in Singaporean patientsChan, Sze Ling ; Chua, Angeline Poh Gek; Aminkeng, Folefac ; Chee, Cynthia Bin Eng; Jin, Shengnan; Loh, Marie ; Gan, Suay Hong; Wang, Yee Tang ; Brunham, Liam R 
51-Nov-2017Association Between SLC16A5 Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular CancerDrogemoller, Britt I; Monzon, Jose G; Bhavsar, Amit P; Borrie, Adrienne E; Brooks, Beth; Wright, Galen EB; Liu, Geoffrey; Renouf, Daniel J; Kollmannsberger, Christian K; Bedard, Philippe L; Aminkeng, Folefac ; Amstutz, Ursula; Hildebrand, Claudette A; Gunaretnam, Erandika P; Critchley, Carol; Chen, Zhuo; Brunham, Liam R; Hayden, Michael R; Ross, Colin JD; Gelmon, Karen A; Carleton, Bruce C
625-Nov-2015Association between the rs12255372 variant of the TCF7L2 gene and obesity in a Cameroonian population ObesityNgwa, EN; Sobngwi, E; Atogho-Tiedeu, B; Noubiap, JJN; Donfack, OS; Guewo-Fokeng, M; Mofo, EPM; Fosso, PP; Djahmeni, E; Djokam-Dadjeu, R; Evehe, MS; Aminkeng, F ; Mbacham, WF; Mbanya, JC
72015Association between the TCF7L2 rs12255372 (G/T) gene polymorphism and type 2 diabetes mellitus in a Cameroonian population: a pilot study.Nanfa, Dieudonne; Sobngwi, Eugene; Atogho-Tiedeu, Barbara; Noubiap, Jean Jacques N; Donfack, Olivier Sontsa; Mofo, Edith Pascale Mato; Guewo-Fokeng, Magellan; Nguimmo Metsadjio, Aurelie; Ndonwi Ngwa, Elvis; Pokam Fosso, Priscille; Djahmeni, Eric; Djokam-Dadjeu, Rosine; Evehe, Marie-Solange; Aminkeng, Folefac ; Mbacham, Wilfred F; Mbanya, Jean Claude
81-Dec-2010Association of IL-2RA/CD25 with type 1 diabetes in the Belgian populationAminkeng, Folefac ; Weets, Ilse; Van Autreve, Jan E; Koeleman, Bobby PC; Quartier, Erik; Van Schravendijk, Chris; Gorus, Frans K; Van der Auwera, Bart JR
91-Jun-2009Association of KIR2DL2 polymorphism rs2756923 with type 1 diabetes and preliminary evidence for lack of inhibition through HLA-C1 ligand bindingRamos-Lopez, E; Scholten, F; Aminkeng, F ; Wild, C; Kalhes, H; Seidl, C; Tonn, T; Van der Auwera, B; Badenhoop, K
101-Jan-2014Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: Relation to autoantibody status and comparison with Belgian patientsAsanghanwa, Milca; Gorus, Frans K; Weets, Ilse; Auwera, Bart V der; Aminkeng, Folefac ; Mbunwe, Eric; Goubert, Patrick; Verhaeghen, Katrijn; Sobngwi, Eugene; Wenzlau, Janet M; Hutton, John C; Pipeleers, Daniel G; Keymeulen, Bart; Mbanya, Jean-Claude N; van Schravendijk, Chris
111-Aug-2016Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic MarkersLee, JW; Pussegoda, K; Rassekh, SR; Monzon, JG; Liu, G; Hwang, S; Bhavsar, AP; Pritchard, S; Ross, CJ; Amstutz, U; Carleton, BC; Hayden, MR; MacLeod, S; Smith, A ; Brunham, L ; Aminkeng, F ; Shear, NH; Koren, G; Ito, S; Madadi, P; Rieder, MJ; Kim, R; Maher, M; Flockhart, D
121-Aug-2018Common variation near IRF6 is associated with IFN-beta-induced liver injury in multiple sclerosisKowalec, Kaarina; Wright, Galen EB; Drogemoller, Britt I; Aminkeng, Folefac ; Bhavsar, Amit P; Kingwell, Elaine; Yoshida, Eric M; Traboulsee, Anthony; Marrie, Ruth Ann; Kremenchutzky, Marcelo; Campbell, Trudy L; Duquette, Pierre; Chalasani, Naga; Wadelius, Mia; Hallberg, Par; Xia, Zongqi; De Jager, Philip L; Denny, Joshua C; Davis, Mary F; Ross, Colin JD; Tremlett, Helen; Carleton, Bruce C
1314-Apr-2015Contribution of the TCF7L2 rs7903146 (C/T) gene polymorphism to the susceptibility to type 2 diabetes mellitus in CameroonGuewo-Fokeng, M; Sobngwi, E; Atogho-Tiedeu, B; Donfack, OS; Noubiap, JJN; Ngwa, EN; Mato-Mofo, EP; Fosso, PP; Djahmeni, E; Djokam-Dadjeu, R; Evehe, MS; Aminkeng, F ; Mbacham, WF; Mbanya, JC
141-Feb-2019CYP2D6 as a treatment decision aid for ER-positive non-metastatic breast cancer patients: a systematic review with accompanying clinical practice guidelinesDrogemoller, Britt I; Wright, Galen EB; Shih, Joanne; Monzon, Jose G; Gelmon, Karen A; Ross, Colin JD; Amstutz, Ursula; Carleton, Bruce C; Chang, Wan C; Connolly, Mary B; Dionne, Francois; Groeneweg, Gabriella; Loucks, Catrina M; MacLeod, Stuart M; Pritchard, Sheila; Rassekh, Shahrad R; Sanatani, Shubhayan; Bhavsar, Amit P; Rieder, Michael J; Shear, Neil H; Ito, Shinya; Liu, Geoffrey; Khayat, Philip; Bernstein, Daniel; Lesko, Lawrence J; Aminkeng, Folefac 
1528-Jan-2022Cytokine Release Syndrome in Cancer Patients Receiving Immune Checkpoint Inhibitors: A Case Series of 25 Patients and Review of the LiteratureTay, Sen Hee ; Toh, Michelle Min Xuan ; Thian, Yee Liang ; Vellayappan, Balamurugan A ; Fairhurst, Anna-Marie ; Chan, Yiong Huak ; Aminkeng, Folefac ; Bharwani, Lavina D; Huang, Yiqing; Mak, Anselm ; Wong, Alvin Seng Cheong
161-Dec-2015DLL4 loss-of-function heterozygous mutations cause Adams-Oliver syndromeAminkeng, F 
171-Sep-2014EIF2AK4 genetic mutations cause a recessive form of rare and deadly lung disease, pulmonary veno-occlusive diseaseAminkeng, F 
18Sep-2022Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Asian Patients with Advanced NSCLCHuang, Y; Zhao, JJ; Soon, YY; Kee, A; Tay, SH; Aminkeng, F ; Ang, Y; Wong, A; Goh, BC; Soo, R 
1912-May-2023Factors Predictive of Primary Resistance to Immune Checkpoint Inhibitors in Patients with Advanced Non-Small Cell Lung CancerHuang, Yiqing; Zhao, Joseph J; Soon, Yu Yang; Kee, Adrian; Tay, Sen Hee; Aminkeng, Folefac ; Ang, Yvonne; Wong, Alvin SC; Bharwani, Lavina D; Goh, Boon Cher; Soo, Ross A 
201-Nov-2017Genetic Variation in SLC16A5 Confers Protection from Cisplatin-Induced Ototoxicity in Adult Testicular Cancer PatientsDrogemoller, Britt; Monzon, Jose; Bhavsar, Amit; Borrie, Adrienne; Brooks, Beth; Wright, Galen; Liu, Geoffrey; Fadhel, Ehab; Renouf, Daniel; Kollmannsberger, Christian; Bedard, Philippe; Aminkeng, Folefac ; Hildebrand, Claudette; Gunaretnam, Erandika; Critchley, Carol; Chen, Zhou; Brunham, Liam; Hayden, Michael; Ross, Colin; Gelmon, Karen; Carleton, Bruce